Nov 1 |
Abbott Surges After Avoiding Another 'Eye-Popping' Verdict In Baby Formula Trial
|
Nov 1 |
Abbott, Reckitt Stocks Rise on Baby-Formula Lawsuit Win
|
Nov 1 |
Abbott shares rise following baby formula verdict
|
Nov 1 |
Reckitt’s Mead Johnson, Abbott cleared by US court in infant-formula case
|
Nov 1 |
Abbott shares rise after securing first win in premature infant formula trial
|
Nov 1 |
Returns At Abbott Laboratories (NYSE:ABT) Are On The Way Up
|
Nov 1 |
Wall Street Breakfast Podcast: Boeing Aims To Land Union Deal...Again
|
Nov 1 |
Reckitt, Abbott Shares Rise After Baby-Formula Lawsuit Win
|
Nov 1 |
Reckitt, Abbott surge after winning an NEC case
|
Nov 1 |
Decoding Abbott Laboratories (ABT): A Strategic SWOT Insight
|